On the morning of June 17, a delegation led by He Xiaoyan, Party Committee Member and Deputy Director of the Songjiang District Health Commission, as well as Director of the Songjiang District CDC Bureau, visited MACY-PAN to conduct a special research visit and provide guidance on the development of the home hyperbaric oxygen chamber industry, product innovation, and strategic planning in the health and wellness sector. General Manager Mr.Pan and Mrs.Pan of MACY PAN warmly welcomed the delegation and accompanied them throughout the visit and discussions.
During the visit, Director He and her delegation toured the exhibition hall and gained a detailed understanding of the company's complete process, from research and development to manufacturing. As a National High-Tech Enterprise and a Shanghai “Specialized, Refined, Distinctive, and Innovative” Enterprise rooted in Songjiang for 19 years, MACY-PAN has consistently prioritized technological innovation since its establishment in 2007. The company has successfully transformed into China's leading enterprise dedicated to the Mild HBOT chamber market. MACY-PAN has obtained ISO9001 and ISO13485 international quality and management system certifications, applied for a total of 64 patents, and exports its products to more than 120 countries and regions worldwide.
During the tour, the delegation focused on MACY-PAN's core products, including single-person seated hard shell hyperbaric chambers, dual-person hard shell hyperbaric oxygen chambers, and the latest multi-person hyperbaric chambers. Among them, the flagship MACY PAN HE5000 multiplace hyperbaric chamber features intelligent switching between 1.3, 1.5, and 2.0 ATA pressure levels, equipped with a noise reduction system and automatic door design. The chambers can accommodate from one to multiple users simultaneously, redefining the application boundaries of home hyperbaric oxygen therapy. Spacious and comfortable interiors are furnished with comfortable sofa chairs, allowing users to sit or recline while enjoying hyperbaric oxygen therapy, watching movies, or handling work tasks, achieving an organic integration of health management and quality living.
Director He expressed great interest in MACY-PAN's achievements in technological innovation and product upgrades. She also engaged in in-depth discussions with company executives regarding the application prospects of the products in health management, rehabilitation and wellness, and the silver economy.
At the symposium, General Manager Mr.Pan presented an introduction on the company's development history, core technological advantages, domestic and international market presence, and future strategic plans. MACY-PAN's products have served the 2020 Tokyo Olympic Games and the 2022 Beijing Winter Olympic Games, and at the 8th China International Import Expo (CIIE) in 2025, MACY-PAN booth received consultations from 5,000 visitors within five days span and secured orders worth several million yuan.
Director He stated that the Songjiang District Health Commission will continue to support and closely follow the development of outstanding biopharmaceutical and healthcare enterprises within the district. She noted that home hyperbaric chambers, as an emerging sector within the health and wellness industry, hold broad application prospects in disease prevention, rehabilitation therapy, and daily health management. She expressed her expectation that MACY-PAN will continue leveraging its technological leadership to contribute to the development of the health industry in Songjiang and across China.
This research and guidance visit not only represents strong recognition of MACY-PAN's comprehensive capabilities but also serves as a significant boost to the development of the home use hyperbaric oxygen chamber industry. Looking ahead, we will continue to uphold our development philosophy of “Embracing Change and Innovation, Pursuing Continuous Improvement, Creating Quality Products, and Exceeding Customer Expectations.” We will deepen industry-academia-research cooperation with universities and research institutions, increase investment in core technology R&D, and respond to market expectations with higher standards and superior quality, bringing the health benefits of “Made in Shanghai” to more families around the world.
Post time: Jun-23-2026